Dougall WC - Search Results

1

Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.

Qian X, LeVea CM, Freeman JK, Dougall WC, Greene MI. Qian X, et al. Among authors: dougall wc. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1500-4. doi: 10.1073/pnas.91.4.1500. Proc Natl Acad Sci U S A. 1994. PMID: 7509075 Free PMC article.

2

Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response.

Visner GA, Dougall WC, Wilson JM, Burr IA, Nick HS. Visner GA, et al. Among authors: dougall wc. J Biol Chem. 1990 Feb 15;265(5):2856-64. J Biol Chem. 1990. PMID: 2406241 Free article.

3

Carboxyl-terminal deletion and point mutations decrease the transforming potential of the activated rat neu oncogene product.

Mikami Y, Davis JG, Dobashi K, Dougall WC, Myers JN, Brown VI, Greene MI. Mikami Y, et al. Among authors: dougall wc. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7335-9. doi: 10.1073/pnas.89.16.7335. Proc Natl Acad Sci U S A. 1992. PMID: 1354355 Free PMC article.

4

Biological studies and potential therapeutic applications of monoclonal antibodies and small molecules reactive with the neu/c-erbB-2 protein.

Dougall WC, Greene MI. Dougall WC, et al. Cell Biophys. 1994;24-25:209-18. doi: 10.1007/BF02789231. Cell Biophys. 1994. PMID: 7736525 Review.

5

Antibody-structure-based design of pharmacological agents.

Dougall WC, Peterson NC, Greene MI. Dougall WC, et al. Trends Biotechnol. 1994 Sep;12(9):372-9. doi: 10.1016/0167-7799(94)90038-8. Trends Biotechnol. 1994. PMID: 7765190 Free article. Review.

6

Down-regulation of c-neu receptors by nerve growth factor in PC12 cells.

Oshima M, Weiss L, Dougall WC, Greene MI, Guroff G. Oshima M, et al. Among authors: dougall wc. J Neurochem. 1995 Jul;65(1):427-33. doi: 10.1046/j.1471-4159.1995.65010427.x. J Neurochem. 1995. PMID: 7790889

7

Intermolecular association and trans-phosphorylation of different neu-kinase forms permit SH2-dependent signaling and oncogenic transformation.

Qian X, Dougall WC, Fei Z, Greene MI. Qian X, et al. Among authors: dougall wc. Oncogene. 1995 Jan 5;10(1):211-9. Oncogene. 1995. PMID: 7824275

8

Interaction of the neu/p185 and EGF receptor tyrosine kinases: implications for cellular transformation and tumor therapy.

Dougall WC, Qian X, Greene MI. Dougall WC, et al. J Cell Biochem. 1993 Sep;53(1):61-73. doi: 10.1002/jcb.240530108. J Cell Biochem. 1993. PMID: 7901229 Review.

9

Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation.

Samanta A, LeVea CM, Dougall WC, Qian X, Greene MI. Samanta A, et al. Among authors: dougall wc. Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1711-5. doi: 10.1073/pnas.91.5.1711. Proc Natl Acad Sci U S A. 1994. PMID: 7907421 Free PMC article.

10

A structural and kinetic comparison of proto-oncogenic and oncogenic neu holo-receptors expressed in insect cells.

LeVea CM, Myers JN, Dougall WC, Qian X, Greene MI. LeVea CM, et al. Among authors: dougall wc. Receptor. 1993 Winter;3(4):293-309. Receptor. 1993. PMID: 7908242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters